ArticleBMC public health2026
Assessment of knowledge, attitude, and practices towards the usage of antidiabetic drugs for weight loss among Lebanese population.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMore individuals are turning to self-medication with weight-loss drugs, including antidiabetics, without seeking medical advice, often relying on unreliable information from social media, thus posing significant health risks. Another concern in developing countries, like Lebanon, is the easy access to medications without a prescription, thus increasing their availability. This study seeks to assess the Lebanese population's knowledge, attitudes, and practices towards the usage of antidiabetic drugs for weight loss, as well as the factors influencing their knowledge and attitude.
designA cross sectional survey was conducted among the general Lebanese population via different social media platforms.
participantsSix hundred thirteen participants out of 617 were included in the final analysis.
resultsThe majority of the participants demonstrated limited knowledge, with a score of 1.79 ± 1.147. However, respondents portrayed an acceptable attitude, with nearly two-thirds agreeing that there is insufficient supervision in Lebanon regarding the dispensing of antidiabetic medications for weight loss, and emphasizing the necessity for medical supervision upon use. In our study, 11.7% of respondents reported using medication for weight loss purposes with the majority experiencing weight gain following the cessation of these medications.
conclusionsThese findings shed light on the need for awareness and public health interventions focused on enhancing public knowledge regarding the use of drugs for weight loss and their possible side effects, especially off-label drugs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.